Company: WHWK
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023932
Chunk: 259

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 259
---
)$227,319 $— $— $227,319 U.S. government treasury bills1,517 — — 1,517 Corporate bonds— 1,976 — 1,976 Total financial assets$228,836 $1,976 $— $230,812 Fair Value Measurements as of December 31, 2024Level 1Level 2Level 3TotalAssets:Money market funds (1)$27,485 $— $— $27,485 U.S. government treasury bills12,562 — — 12,562 Commercial paper— 1,744 — 1,744 Corporate bonds— 4,261 — 4,261 Total financial assets$40,047 $6,005 $— $46,052 (1)Included in cash and cash equivalents in the accompanying condensed consolidated balance sheets.As of March 31, 2025, marketable securities had a contractual maturity of less than one year.

4. Short-Term Investments and Cash Equivalents

The following table summarizes the Company's short-term investments (in thousands): As of March 31, 2025Maturity               (In Years)Amortized CostUnrealized GainsUnrealized LossesFair ValueMoney market funds$227,319 $— $— $227,319 U.S. government treasury billsLess than 11,517 — — 1,517 Corporate bondsLess than 11,975 1 — 1,976 Total $230,811 $1 $— $230,812 As of December 31, 2024Maturity               (In Years)Amortized CostUnrealized GainsUnrealized LossesFair ValueMoney market funds$27,485 $— $— $27,485 U.S. government treasury billsLess than 112,553 9 — 12,562 Commercial paperLess than 11,743 1 — 1,744 Corporate bondsLess than 14,256 5 — 4,261 Total $46,037 $15 $— $46,052 

14

5. Accrued Liabilities 

Details of accrued liabilities are presented as follows (in thousands):March 31,2025December 31,2024Accru